Literature DB >> 22893407

Investigation and treatment of type 2 diabetes in nonhuman primates.

Barbara C Hansen1.   

Abstract

Nonhuman primates provide the ideal animal model for discovering and examining further the mechanisms underlying human type 2 diabetes mellitus. In all aspects studied to date the nonhuman primate has been shown to develop the same disease with the same features that develop in overweight middle-aged humans. This includes the progressive development of the known complications of diabetes, all of which are extraordinarily like those identified in humans. In addition, for the development and evaluation of new therapeutic agents, the translation of findings from nonhuman primates to application in humans has been highly predictable. Both therapeutic efficacy and identification of potential adverse responses can be effectively examined in nonhuman primates due to their great similarity to humans at the molecular, biochemical, and physiological levels. This chapter provides guidance for the development and management of a colony of monkeys with naturally occurring type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893407     DOI: 10.1007/978-1-62703-068-7_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

Review 1.  The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.

Authors:  Saptarshi Bhattacharya; Sanjay Kalra; Deep Dutta; Deepak Khandelwal; Rajiv Singla
Journal:  Eur Endocrinol       Date:  2019-10-18

Review 2.  The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms.

Authors:  K B King; A K Rosenthal
Journal:  Osteoarthritis Cartilage       Date:  2015-03-30       Impact factor: 6.576

3.  Endocannabinoid hydrolase and cannabinoid receptor 1 are involved in the regulation of hypothalamus-pituitary-adrenal axis in type 2 diabetes.

Authors:  Qihui Luo; Shanshan Chen; Juan Deng; Liangqin Shi; Chao Huang; Anchun Cheng; Wentao Liu; Jing Fang; Li Tang; Yi Geng; Zhengli Chen
Journal:  Metab Brain Dis       Date:  2018-06-11       Impact factor: 3.584

4.  Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test.

Authors:  Michael Staup; George Aoyagi; TeQuana Bayless; Yixin Wang; Keefe Chng
Journal:  J Vis Exp       Date:  2016-11-13       Impact factor: 1.355

5.  Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates.

Authors:  Kamal Albarazanji; Andrea R Nawrocki; Bin Gao; Xiaoli Wang; Yixin Jim Wang; Yong-Fu Xiao
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

6.  LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys.

Authors:  Andrew C Adams; Carolyn A Halstead; Barbara C Hansen; Armando R Irizarry; Jennifer A Martin; Sharon R Myers; Vincent L Reynolds; Holly W Smith; Victor J Wroblewski; Alexei Kharitonenkov
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

7.  Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging.

Authors:  Can Qian; Li Gong; Zunyuan Yang; Wei Chen; Yushu Chen; Ziqian Xu; Bing Wu; Chungui Tang; Fabao Gao; Wen Zeng
Journal:  BMC Cardiovasc Disord       Date:  2015-06-26       Impact factor: 2.298

8.  Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.

Authors:  Effie Tozzo; Gowri Bhat; Kyeongmi Cheon; Raul C Camacho
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

9.  Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.

Authors:  Jennifer L Fiori; Yu-Kyong Shin; Wook Kim; Susan M Krzysik-Walker; Isabel González-Mariscal; Olga D Carlson; Mitesh Sanghvi; Ruin Moaddel; Kathleen Farhang; Shekhar K Gadkaree; Maire E Doyle; Kevin J Pearson; Julie A Mattison; Rafael de Cabo; Josephine M Egan
Journal:  Diabetes       Date:  2013-07-24       Impact factor: 9.461

10.  Quantification of β-cell insulin secretory function using a graded glucose infusion with C-peptide deconvolution in dysmetabolic, and diabetic cynomolgus monkeys.

Authors:  Xiaoli Wang; Barbara C Hansen; Da Shi; Yupeng Fang; Fenglai Du; Bingdi Wang; Yaxiong Michael Chen; Francine M Gregoire; Yi-Xin Jim Wang
Journal:  Diabetol Metab Syndr       Date:  2013-07-25       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.